Hexa Research
Fact-based market research, penetrating industry insights and validated forecasts to help you make better decisions for a stronger future
Browse Details of Report @ https:// www. hexaresearch. com / research-report / respiratorysyncytial-virus-diagnostics-market
The global RSV Diagnostics market is categorized on the basis of products, end use, and regions. On the basis of products, the segments are DFA( direct fluorescence antibody) method, RADTs( rapid antigen diagnostic tests), flow cytometry, molecular diagnostics, gel microdroplets, diagnostic imaging, chromatographic immunoassay, and others. Due to high accuracy & precision, the molecular diagnostics segment may lead the overall industry during the forecast period.
Based on end uses, the industry is divided into clinics, hospitals, homecare, and laboratory. Hospitals held the largest share in 2015. It is expected that this segment will continue dominating the RSV Diagnostics market because of high hospitalization rate of RSV infected patients.“ Homecare” too may expand significantly in the forthcoming years because of high demand for perinatal & in-house testing. Surging popularity of homecare services owes to high governmental investments in training programs for the same.
Geographically, the global Respiratory Syncytial Virus Diagnostics Market is segmented into Latin America, Europe, North America, Asia Pacific, and the Middle East & Africa. With a market share surpassing 45 %, North America led the industry in 2015. This region is propelled by high incidence of respiratory tract infections. Governmental initiatives, such as PAHO( Pan American Health Organization) may significantly contribute to market demand over the next couple of years. As per this initiative, it is absolutely necessary to rule out the possibilities of infections & metabolic defects in newborns.
Asia Pacific may register a high growth rate from 2016 to 2024. High incidence of infectious diseases fueled by moderate to poor living conditions propels this regional market. Other factors that may drive this region are improved healthcare infrastructure, high R & D funding, favorable government mandates, and steady technological advancements.
Contact: + 1-800-489-3075
Email: sales @ hexaresearch. com Website: http:// www. hexaresearch. com /